Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Retained Earnings (2016 - 2025)

Tg Therapeutics has reported Retained Earnings over the past 10 years, most recently at -$1.1 billion for Q4 2025.

  • Quarterly results put Retained Earnings at -$1.1 billion for Q4 2025, up 28.07% from a year ago — trailing twelve months through Dec 2025 was -$1.1 billion (up 28.07% YoY), and the annual figure for FY2025 was -$1.1 billion, up 28.07%.
  • Retained Earnings for Q4 2025 was -$1.1 billion at Tg Therapeutics, roughly flat from -$1.1 billion in the prior quarter.
  • Over the last five years, Retained Earnings for TGTX hit a ceiling of -$1.1 billion in Q1 2021 and a floor of -$1.6 billion in Q2 2023.
  • Median Retained Earnings over the past 5 years was -$1.5 billion (2022), compared with a mean of -$1.4 billion.
  • Biggest five-year swings in Retained Earnings: plummeted 46.22% in 2021 and later skyrocketed 30.93% in 2025.
  • Tg Therapeutics' Retained Earnings stood at -$1.3 billion in 2021, then fell by 12.89% to -$1.5 billion in 2022, then dropped by 3.51% to -$1.6 billion in 2023, then grew by 1.51% to -$1.5 billion in 2024, then grew by 28.07% to -$1.1 billion in 2025.
  • The last three reported values for Retained Earnings were -$1.1 billion (Q4 2025), -$1.1 billion (Q3 2025), and -$1.5 billion (Q2 2025) per Business Quant data.